Sinusoidal Obstruction Syndrome Is a Major Feature of Hepatic Lesions Associated with Oxaliplatin Neoadjuvant Chemotherapy for Liver Colorectal Metastases
Authors:
- Laura Rubbia-BrandtLRLaura Rubbia-Brandt
- Gilles MenthaGMGilles Mentha
- Benoit TerrisBTBenoit Terris
- 1 January 2006
- journal article
- other
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 202 (1) , 199-200
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal MetastasesJournal of the American College of Surgeons, 2005
- Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I–II studyAnnals of Oncology, 2005
- Oxaliplatin Toxicity Masquerading As Recurrent Colon CancerJournal of Clinical Oncology, 2004
- Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerAnnals of Oncology, 2004
- Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic ConferenceHepatology, 2003
- Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)Seminars in Liver Disease, 2002